Skip to main content

Make more Ebola drug and give it to Africans

By Harriet A. Washington
updated 4:21 PM EDT, Wed August 6, 2014
STORY HIGHLIGHTS
  • Americans with Ebola received an experimental medicine that seemed to help
  • Harriet Washington: Poor Africans don't have access to lifesaving medicines
  • She says access to drugs often based on how much money you have and if you're a Westerner
  • She urges this drug be made in quantity and given to infected West Africans in a trial

Editor's note: Harriet A. Washington, a fellow at the Black Mountain Institute at the University of Nevada, Las Vegas, is the author of "Medical Apartheid: The Dark History of Experimentation from Colonial Times to the Present" and "Deadly Monopolies: The Shocking Corporate Takeover of Life Itself -- and the Consequences for Your Health and Our Medical Future." The opinions expressed in this commentary are solely those of the writer.

(CNN) -- One of the many questions surrounding the revelation that Americans Kent Brantly and Nancy Writebol received a little-known, experimental serum for their Ebola infection is: "Why did we hear nothing about it earlier, and how did they gain access to it?"

Ebola has no cure, although potential medications and vaccines are in various states of development. The serum ZMapp, an experimental product of Mapp Biopharmaceutical, hasn't been tested in humans, which means it doesn't meet a primary requirement for FDA approval -- so its obscurity is no surprise.

The Americans managed to gain access to what more than 1,660 infected people in Guinea, Sierra Leone, Liberia and now Nigeria did not: medicine that seems to work -- although, of course, we don't know for sure yet. Some reports indicate they received ZMapp under the FDA's "compassionate use" rule, which permits untested drugs to be given to consenting patients who might otherwise die. This is a triumph of common sense and compassion over bureaucratic red tape.

Harriet A. Washington
Harriet A. Washington

One of the chief concerns about using unapproved medications is that we don't know what the risks are: The drug may not work, it may work with serious adverse effects, or it may prove as deadly as the disease. But as a doctor, Brantly understood the risks, and like him, Writebol had no other options. Most people with Ebola die.

Compassionate use is certainly ethically defensible. But apparently only three doses were available, and they were given to Westerners. The lack of broader access to ZMapp highlights what is often a very serious ethical failing.

9 questions about this new Ebola drug

Marie Nyan, whose mother died of Ebola, carries her 2-year-old son, Nathaniel Edward, to an ambulance after showing signs of the virus in the Liberian village of Freeman Reserve on Tuesday, September 30. Health officials say the Ebola outbreak in West Africa is the deadliest ever. More than 3,000 people have died, according to the World Health Organization. Marie Nyan, whose mother died of Ebola, carries her 2-year-old son, Nathaniel Edward, to an ambulance after showing signs of the virus in the Liberian village of Freeman Reserve on Tuesday, September 30. Health officials say the Ebola outbreak in West Africa is the deadliest ever. More than 3,000 people have died, according to the World Health Organization.
Ebola outbreak in West Africa
HIDE CAPTION
<<
<
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
>
>>
Photos: Ebola outbreak in West Africa Photos: Ebola outbreak in West Africa

Why didn't Dr. Sheik Umar Khan, the chief Sierra Leone physician who died while treating Ebola patients, receive this medication? Because another method of determining who gets medications is at work here -- the drearily familiar stratification of access to a drug based on economic resources and being a Westerner rather than a resident of the global South.

Ebola vaccine delayed for business reasons?
How the experimental Ebola serum works
Fight against Ebola given new momentum

No health worker wants to intentionally deprive Africans of a needed drug. But informal medical networks, which Africans lack, connect well-to-do Westerners with information and drugs. In addition, the pharmaceutical industry has a history of declining to test medications for diseases of the tropical world, most of whose inhabitants cannot afford high prices.

We don't know how quickly ZMapp could be made in large quantities. If it were to be made available, who should receive it? Some think Ebola doctors and caregivers should, because their survival is essential to treating and quelling the epidemic. This makes sense, but it's not that simple.

First, it violates the principle of distributive justice: The benefits of the drug are being inequitably distributed, with skilled, economically secure professionals more likely to benefit.

Also, by what reckoning do we decide that the doctors' role increases their value and dictates they should be given a preferential chance to survive? Distributing the drug through a clinical trial would allow us to know whether and how well the medication works and what caveats might apply.

Africans must participate in any clinical trial, which would benefit the pharmaceutical company as well as, it's hoped, Ebola victims. This would mean their lives have irreplaceable value, too, in the equation of who should get the drug.

So, will Africans receive this potentially lifesaving medication?

A U.N. official suggested that drugs cannot be tested in the middle of an epidemic -- but he is wrong. Such tests are conducted all the time.

Dr. David Ho tested AIDS drugs in Uganda in the midst of the pandemic, and the meningitis drug Trovan was tested in Kano, Nigeria, in the midst of an epidemic. One of every three industry trials is conducted in developing countries; scientists often point to high disease rates, including epidemics, as a rationale for conducting them there.

The problem is not testing the drug amid an epidemic. The question is how ethically such trials are conducted.

Only small amounts of ZMapp are available now, but as soon as it can be made in quantity, the drug for Ebola should be made available to Africans in all the regions that are threatened by the epidemic, regardless of ability to pay.

If possible, it should be distributed within clinical trials to determine the safety and efficiency of the medications. Many people assume this requires withholding medications in a control group, but this is not necessarily the case. Experts should and can mount a well-designed study that permits early access to the medication to all who need it.

But if they cannot ensure that sick people get the drug early, then a clinical trial should not be any more of a requirement for poor Africans than it was for Kent Brantly.

It's also natural to wonder whether the threat of Ebola to the Western world, not to Africans, drives this initiative because so few such drugs are devised for Africans.

This simply highlights another reason why we should so our utmost to protect people from Ebola: our medical interdependence. If Ebola makes landfall in the United States, we will need drugs like ZMapp, just as Africans need them today.

Read CNNOpinion's new Flipboard magazine.

Follow us on Twitter @CNNOpinion.

Join us on Facebook.com/CNNOpinion.

Part of complete coverage on
updated 12:53 PM EDT, Tue September 30, 2014
Jeff Yang calls Ello a wakeup call to Facebook and Twitter, and a sign of hope for fast-rising upstarts Pinterest and Snapchat.
updated 6:48 PM EDT, Tue September 30, 2014
Paul Waldman says the Secret Service should examine its procedures to make sure there are no threats to the White House--but without losing the openness so valuable to democracy
updated 4:49 PM EDT, Tue September 30, 2014
Jesse Williams says the videotape and 911 call that resulted in police gunning down John Crawford at a Walmart reveals the fatal injustice of racial assumptions
updated 7:03 PM EDT, Tue September 30, 2014
Mel Robbins says officials should drop the P.C. pose: The beheading in Oklahoma was not workplace violence. Plenty of evidence shows Alton Nolen was an admirer of ISIS.
updated 3:11 PM EDT, Tue September 30, 2014
The Occupy Central movement has already achieved much by bringing greater attention to Hong Kong's struggle for democracy, William Piekos says..
updated 3:11 PM EDT, Tue September 30, 2014
The Occupy Central movement has already achieved much by bringing greater attention to Hong Kong's struggle for democracy, writes William Piekos.
updated 10:13 AM EDT, Tue September 30, 2014
As Prime Minister Narendra Modi visits America, Madeleine Albright says a world roiled by conflict needs these two great democracies to commit to moving their partnership forward
updated 10:04 AM EDT, Tue September 30, 2014
John Sutter: Lake Providence, Louisiana, is the parish seat of the "most unequal place in America." And until somewhat recently, the poor side of town was invisible on Google Street View.
updated 9:11 AM EDT, Mon September 29, 2014
Julian Zelizer says in the run up to the 2016 election the party faces divisions on its approach to the U.S.'s place in the world
updated 10:19 AM EDT, Mon September 29, 2014
Ruben Navarrette says Common Core supporters can't devise a new set of standards and then fail to effectively sell it.
updated 9:29 AM EDT, Tue September 30, 2014
Earlier this month, Kenyans commemorated the heinous attack on the Westgate Mall in Nairobi.
updated 2:59 PM EDT, Tue September 30, 2014
David Wheeler says Colorado students are right to protest curriculum changes that downplays civil disobedience.
updated 9:58 PM EDT, Fri September 26, 2014
Sally Kohn says when people click on hacked celebrity photos or ISIS videos, they are encouraging the bad guys.
updated 7:55 AM EDT, Fri September 26, 2014
Loren Bunche says she walked by a homeless man every day and felt bad about it -- until one day she paused to get to know him
updated 9:32 AM EDT, Tue September 30, 2014
ISIS grabs headlines on social media, but hateful speech is no match for moderate voices, says Nadia Oweidat.
updated 8:33 AM EDT, Mon September 29, 2014
A new report counts jihadists fighting globally. The verdict? The threat isn't that big, says Peter Bergen.
updated 5:37 PM EDT, Tue September 23, 2014
Ebola could become the biggest humanitarian disaster in a generation, writes former British Prime Minister Tony Blair
updated 12:58 PM EDT, Fri September 26, 2014
ISIS has shocked the world. But will releasing videos of executions backfire? Four experts give their take.
updated 10:39 AM EDT, Fri September 26, 2014
Eric Holder kicked off his stormy tenure as attorney general with a challenge to the public that set tone for six turbulent years as top law-enforcement officer.
updated 9:09 AM EDT, Fri September 26, 2014
LZ Granderson says Obama was elected as a war-ending change agent, not a leader who would leave behind for his successor new engagement in Iraq and Syria. Is he as disappointed as the rest of us?
updated 5:10 AM EDT, Wed September 24, 2014
Gayle Lemmon says the question now is how to translate all the high-profile feminizing into real gains for women
ADVERTISEMENT
ADVERTISEMENT
ADVERTISEMENT
ADVERTISEMENT